Literature DB >> 13919955

"Colomycin". Laboratory and clinical investigations.

G TAYLOR, H ALLISON.   

Abstract

Keywords:  ANTIBIOTICS/therapy; PSEUDOMONAS INFECTIONS/therapy; SURGERY, OPERATIVE/complications; URINARY TRACT INFECTIONS/therapy; VARICOSE ULCER/therapy

Mesh：

Substances：

Year:  1962        PMID： 13919955      PMCID： PMC1925348          DOI： 10.1136/bmj.2.5298.161

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  5 in total

1.  Colistin (coly-mycin) in resistant bacterial infections. A clinical appraisal.

Authors:  E M YOW; E TAN; L SHANE; S SCHONFELD; H ABU-NASSAR
Journal:  Arch Intern Med       Date:  1961-11

2.  The use of colymycin in chronic urinary infections due to Pseudomonas aeuroginosa.

Authors:  G CARROLL; W F MALETTE
Journal:  J Urol       Date:  1961-01       Impact factor: 7.450

3.  Intraventricular administration of a new derivative of polymyxin B in meningitis due to Ps. pyocyanea.

Authors:  H E CLIFFORD; G T STEWART
Journal:  Lancet       Date:  1961-07-22       Impact factor: 79.321

4.  [Observations on the in vitro activity of colimycin].

Authors:  Y CHABBERT
Journal:  Minerva Med       Date:  1958-12-05       Impact factor: 4.806

5.  The use of colistin in the treatment of infections of the urinary tract.

Authors:  R G PETERSDORF; E W HOOK
Journal:  Bull Johns Hopkins Hosp       Date:  1960-09
  5 in total
  2 in total

1.  Sodium sulphomethyl derivatives of polymyxins.

Authors:  E G Beveridge; A J Martin
Journal:  Br J Pharmacol Chemother       Date:  1967-02

2.  SYNERGISM BETWEEN SULPHONAMIDE DRUGS AND ANTIBIOTICS OF THE POLYMYXIN GROUP AGAINST PROTEUS SP. IN VITRO.

Authors:  F E RUSSELL
Journal:  J Clin Pathol       Date:  1963-07       Impact factor: 3.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.